Kiniksa Pharmaceuticals International Plc. Other Current Assets

As of the most recent data (September 2026), KNSA shows a other current assets of $43M. That compares with $120M in the prior-year period — down 65.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, KNSA's other current assets is now $43M (was $120M) — a 65.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Kiniksa Pharmaceuticals International Plc. is outperforming or lagging.

Tracking KNSA's other current assets over time shows whether Kiniksa Pharmaceuticals International Plc. is scaling, shrinking, or reshaping that part of the business. The current reading is $43M That compares with $120M in the prior-year period — down 65.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Kiniksa Pharmaceuticals International Plc.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $43M) with ownership activity and broader fundamentals.

Kiniksa Pharmaceuticals International Plc.'s other current assets is $43M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.